⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →

Themis Medicare Limited (THEMISMED) — Announcement | 13 August 2026(3 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team • AI-Assisted Analysis • Source: BSE/NSE Filings
1 Announcement 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Board approves new Company Secretary and KMP effective August 13, 2026
💡 Investor Takeaway
The leadership change in compliance roles may affect governance continuity but does not alter core financial performance.

Themis Medicare announced the appointment of Suresh Savaliya as Company Secretary and Key Managerial Personnel effective August 13, 2026, following the resignation of Nagraj Mogaveera on the same day. The board approved both changes during a meeting that reviewed Q1 FY2026 financial results.

2 Announcement 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Board approves Q1 results and appoints new Company Secretary
💡 Investor Takeaway
The leadership change may affect governance continuity but does not impact current financial performance.

Themis Medicare announced board approval of Q1 FY26 unaudited financial results and announced the resignation of interim Company Secretary Nagraj Mogaveera effective August 13, 2026, replaced by Suresh Savaliya as new Company Secretary, Compliance Officer and Key Managerial Personnel.

3 Announcement Neutral 📄 PDF
📢 Key Event
Themis Medicare presents Q1 FY27 results and strategic outlook
🔄 What Changed
Revenue grew 10.9% YoY; PAT shifted from ₹14.1 crore loss to ₹24.6 crore profit
🔮 What's Next
Focus on hospital business leadership, expansion into new markets, and continued R&D investment
💡 Investor Takeaway
Shareholders see improved profitability and strategic momentum after a loss-making prior year quarter.

Themis Medicare Limited released its Q1 FY27 investor presentation highlighting a 10.9% YoY revenue increase to ₹86.96 crore and a turnaround from a ₹14.1 crore loss to a ₹24.6 crore PAT, driven by one-off gains and improved profitability. The presentation details financial highlights, business segment performance, and strategic growth plans for hospital and API segments.

⚡ StockFin Pro 100-stock AI Radar. No daily limits. No ads. View Plans →
📊 Stock Analysis — THEMISMED ✨ Ask AI About This

About Themis Medicare Limited (THEMISMED)

Healthcare · Pharmaceuticals · Listed on NSE

Market Cap: ₹1,142.96 Cr P/E: 28.6 ROE: 9.9% ROCE: 13.6% Div Yield: 0.40%

View full THEMISMED stock details →

📡 Get AI alerts when THEMISMED files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track THEMISMED — Free

💡 Ask AI about this filing

Ask AI Free →

📊 More THEMISMED filings

See all THEMISMED filings →

🔥 Also filed on 13 August 2026

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when THEMISMED files new disclosures

Track THEMISMED filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track THEMISMED — Free

Free account · 2 AI queries/day

⚡ StockFin Pro Go Pro — bigger Radar, no daily limits Upgrade

© 2026 StockFin.ai — AI-powered Indian stock research

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd